Calorie restriction (CR), which deactivates the nutrient-sensing mTOR pathway, slows down aging and prevents age-related diseases such as type II diabetes. Compared with CR, rapamycin more efficiently inhibits mTOR. Noteworthy, severe CR and starvation cause a reversible condition known as "starvation diabetes. " As was already discussed, chronic administration of rapamycin can cause a similar condition in some animal models. A recent paper published in Science reported that chronic treatment with rapamycin causes a diabetes-like condition in mice by indirectly inhibiting mTOR complex 2. Here I introduce the notion of benevolent diabetes and discuss whether starvation-like effects of chronic high dose treatment with rapamycin are an obstacle for its use as an anti-aging drug. © Blagosklonny.
CITATION STYLE
Blagosklonny, M. V. (2012). Once again on rapamycin-induced insulin resistance and longevity: Despite of or owing to. Aging, 4(5), 350–358. https://doi.org/10.18632/aging.100461
Mendeley helps you to discover research relevant for your work.